Ivan Leo Pinto
Ivan Leo Pinto, Essex GB
Patent application number | Description | Published |
---|---|---|
20100168122 | XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS - The present invention relates to compounds of formula (I) which are xanthine derivatives, processes for manufacture of said derivatives, pharmaceutical formulations containing these compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial | 07-01-2010 |
20100179128 | XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS - The present invention relates to compounds of formula (I) which are xanthine derivatives, processes for the manufacture of said derivatives, pharmaceutical formulations containing these active compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial | 07-15-2010 |
20150045375 | NOVEL COMPOUNDS - Pyrimidone compounds of formula (I): | 02-12-2015 |
Ivan Leo Pinto, Stevenage GB
Patent application number | Description | Published |
---|---|---|
20100010021 | NOVEL COMPOUNDS - The present invention relates to therapeutically active xanthine derivative compounds of Formula (I): | 01-14-2010 |
20100160354 | NOVEL COMPOUNDS - The present invention relates to therapeutically active xanthine derivative compounds of Formula (I): | 06-24-2010 |
20130150383 | NOVEL COMPOUNDS - The present invention relates to therapeutically active xanthine derivative compounds of Formula (I): | 06-13-2013 |
20150080418 | NOVEL COMPOUNDS - The present invention relates to therapeutically active xanthine derivative compounds of Formula (I): | 03-19-2015 |
Ivan Leo Pinto, Harlow GB
Patent application number | Description | Published |
---|---|---|
20090118313 | Novel Compounds - Pyrimidone compounds of formula (I): | 05-07-2009 |
20090170877 | 5,6-Trimethylenepyrimidin-4-one compounds - Pyrimidone compounds of formula (I): | 07-02-2009 |
20100144765 | 5,6-TRIMETHYLENEPYRIMIDIN-4-ONE COMPOUNDS - Pyrimidone compounds of formula (I): | 06-10-2010 |
20110257205 | XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS - The present invention relates to compounds which are xanthine derivatives, processes for the manufacture of said derivatives, pharmaceutical formulations containing these compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial. | 10-20-2011 |
20120172378 | NOVEL COMPOUNDS - Pyrimidone compounds of formula (I): | 07-05-2012 |
Ivan Leo Pinto, Hertfordshire GB
Patent application number | Description | Published |
---|---|---|
20080200468 | 2-Substituted 5-Membered Heteroaryl Carboxylates as Hm74a Receptor Agonists - Therapeutically active heteroaryl carboxylic acid derivatives of Formula (I) wherein R | 08-21-2008 |
20080214638 | Anthranilic Acid Derivatives Active as the Hm74a Receptor - Therapeutically active anthranilic acid derivatives of Formula (I) or of Formula (Ia) wherein R, R | 09-04-2008 |
20090209561 | Xanthine Derivatives with HM74A Receptor Activity - The present invention relates to therapeutically active xanthine compound derivatives, corresponding pharmaceutical formulations containing, processes for making or manufacture and the use of the aforementioned compounds in therapy, particularly in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial. | 08-20-2009 |
Ivan Leo Pinto, Hertfordshire DE
Patent application number | Description | Published |
---|---|---|
20080221108 | Anthranilic Acid Derivatives As Hm74A Receptor Agonists - Therapeutically active anthranilic acid derivatives of Formula (I) wherein R | 09-11-2008 |